Published in Thromb Res on December 01, 1990
Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother (1968) 2.74
Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes. Br J Pharmacol (1968) 1.80
Subcellular localization of 5-hydroxytryptamine and histamine in blood platelets. Nature (1967) 1.63
Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase. J Pharmacol Exp Ther (1968) 1.54
In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature (1974) 1.51
Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature (1967) 1.44
The controversial early history of cyclosporin. Swiss Med Wkly (2001) 1.43
Micelle formation between 5-hydroxytryptamine and adenosine triphosphate in platelet storage organelles. Science (1969) 1.43
Enhancement of noradrenaline turnover in rat brain by L-dopa. J Pharm Pharmacol (1974) 1.43
Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine. J Pharm Pharmacol (1969) 1.35
Metal-dependent aggregation of biogenic amines: a hypothesis for their storage and release. Nature (1969) 1.31
Two sites of 5-hydroxytryptamine uptake in blood platelets. Life Sci (1967) 1.31
A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol Psychiatry (2008) 1.20
Electron microscopic study of the storage site of 5-hydroxytryptamine in blood platelets. Adv Pharmacol (1968) 1.18
3-O-methyldopa, a new precursor of dopamine. Nature (1971) 1.17
Two types of 5-hydroxytryptamine release from isolated blood platelets. Experientia (1964) 1.17
Decarboxylase inhibitors. Pharmacol Ther B (1975) 1.15
Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. Brain Res (1967) 1.14
Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J Pharm Pharmacol (1968) 1.14
5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number. Thromb Haemost (1988) 1.13
Metabolism, subcellular transport and storage of 5-hydroxytryptamine in blood platelets. Ann Med Exp Biol Fenn (1968) 1.11
Monoamine oxidase inhibitors. Pharmacol Rev (1966) 1.09
Atropine-induced changes of cerebral dopamine turnover. Experientia (1971) 1.09
Adenine-, guanine- and uridine-5'-phosphonucleotides in blood platelets and storage organelles of various species. J Pharmacol Exp Ther (1971) 1.07
The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Clin Pharmacol Ther (1971) 1.06
Differential uptake of biogenic amines by isolated 5-hydroxytryptamine organelles of blood platelets. Life Sci (1969) 1.03
L-dopa-induced accumulation of 3-O-metyldopa in brain and heart. Eur J Pharmacol (1970) 1.03
Effect of drugs and cations on ultrastructure and 5-hydroxytryptamine content of blood platelets. J Pharmacol Exp Ther (1967) 1.01
Dissociation between biochemical and ultrastructural effects of 6-hydroxydopamine in rat brain. Experientia (1970) 1.01
Shape change of blood platelets--a model for cerebral 5-hydroxytryptamine receptors? Br J Pharmacol (1979) 1.01
New aspects on the storage of 5-hydroxytryptamine in blood platelets. Experientia (1971) 1.00
Rapid characterization of molecular chemistry, nutrient make-up and microlocation of internal seed tissue. J Synchrotron Radiat (2007) 0.99
Action of reserpine and imipramine on intracellular storage of 5-hydroxytryptamine in blood platelets. Experientia (1967) 0.99
Temperature sensitivity of the passive outflow of 5-hydroxytryptamine from blood platelets. Life Sci (1965) 0.98
Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets. Eur J Pharmacol (1985) 0.97
Activation of tyrosine hydroxylation in rat brain in vivo by chlorpromazine. Nature (1967) 0.97
Subcellular localization of the heparin-neutralizing factor in blood platelets. J Physiol (1976) 0.97
Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats. Brain Res (1973) 0.96
Storage of exogenous monoamines and reserpine in 5-hydroxytryptamine organelles of blood platelets. Eur J Pharmacol (1969) 0.96
Physico-chemical properties of 5-hydroxytryptamine organelles of blood platelets. Agents Actions (1969) 0.95
Distribution and metabolism of L-3-O-methyldopa in rats. Br J Pharmacol (1970) 0.95
Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits. Br J Pharmacol (1981) 0.94
Metal-dependent aggregation of nucleotides with formation of biphasic liquid systems. Biochim Biophys Acta (1970) 0.93
Drug-induced changes of extracerebral dopa metabolism in man. Arch Neurol (1969) 0.93
Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain. Experientia (1968) 0.92
Storage of 5-hydroxytryptamine in human blood platelets. Experientia (1972) 0.92
Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine. Brain Res (1974) 0.92
Action of reserpine on subcellular 5-hydroxytryptamine organelles of blood platelets. Life Sci (1968) 0.92
Phase separation in solutions of noradrenaline and adenosine triphosphate: influence of bivalent cations and drugs. Br J Pharmacol (1970) 0.92
The new generation of monoamine oxidase inhibitors. Prog Drug Res (1992) 0.92
Effects of clozapine on cerebral catecholaminergic neurone systems. Br J Pharmacol (1972) 0.91
Mepacrine, a tool for investigating the 5-hydroxytryptamine organelles of blood platelets by fluorescence microscopy. J Lab Clin Med (1977) 0.91
Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Nature (1974) 0.90
Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.90
Storage of catecholamines in adrenal medullary granules: formation of aggregates with nucleotides. Life Sci I (1971) 0.90
Different localization of reserpine and tyramine within the 5-hydroxytryptamine organelles of blood platelets. Experientia (1969) 0.89
Storage of 5-hydroxytryptamine in megakaryocytes. J Cell Biol (1972) 0.89
Formation of 5-hydroxytryptophol by blood platelets after thrombin and reserpine. Experientia (1965) 0.89
Effect of monoamine liberators on the metabolism of 5-hydroxytryptamine in blood platelets. Biochem Pharmacol (1965) 0.89
Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance. Cardiovasc Drugs Ther (1990) 0.89
Molecular organization of amine storage organelles of blood platelets and adrenal medulla. Adv Cytopharmacol (1974) 0.89
Aralkylamines with different effects on the metabolism of aromatic monoamines. J Pharmacol Exp Ther (1966) 0.89
Effect of neuroleptics and other drugs on monoamine uptake by membranes of adrenal chromaffin granules. Br J Pharmacol (1977) 0.89
Flashing phenomenon in blood platelets stained with fluorescent basic drugs. Experientia (1975) 0.88
Storage of biogenic amines in blood platelets and adrenal medulla. Lack of evidence for direct involvement of glycosaminoglycans. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.88
On the origin of homovanillic acid in the cerebrospinal fluid. Experientia (1966) 0.87
The metabolic pathways of L-3-O-methyldopa. J Pharmacol Exp Ther (1972) 0.87
Transfer and storage of biogenic monoamines in subcellular organelles of blood platelets. Prog Brain Res (1969) 0.87
Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs. Life Sci (1979) 0.87
Distribution and metabolism of DL-3,4-dihydroxy[2-14C]-phenylalanine in rat tissues. Biochem J (1964) 0.86
Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. Biochem Biophys Res Commun (1991) 0.86
On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J Pharm Pharmacol (1966) 0.86
Vascular smooth muscle cell calcium fluxes. Regulation by angiotensin II and lipoproteins. Hypertension (1993) 0.86
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors. Br J Pharmacol (1985) 0.84
Blood platelets isolated by polysaccharide gradients: reaction to 5-hydroxytryptamine. J Lab Clin Med (1979) 0.84
Temperature dependence of the passive in- and outflow of 5-hydroxytryptamine in blood platelets. Biochem Pharmacol (1966) 0.83
Platelets as models for monoaminergic neurons. Essays Neurochem Neuropharmacol (1978) 0.83
Enhancement of tyrosine hydroxylation within the brain by chlorpromazine. Experientia (1969) 0.83
Two types of monoamine liberation by chlorinated aralkylamines. Life Sci (1965) 0.83
Mechanisms of 5-hydroxytryptamine storage in subcellular organelles of blood platelets. Adv Biochem Psychopharmacol (1974) 0.83
Discrimination of monoamine uptake by membranes of adrenal chromaffin granules. Br J Pharmacol (1975) 0.83
A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover. J Pharmacol Exp Ther (1977) 0.83
Lipid composition of membranes of amine-storage organelles. Biochem J (1972) 0.83
Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies. J Neurol (2000) 0.82
Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs. Eur J Pharmacol (1973) 0.82
Interaction of aggregated catecholamines and nucleotides with intragranular proteins. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.82
Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiency. J Pharm Pharmacol (1975) 0.82
Effects of benzoquinolizines and ring-substituted aralkylamines on serotonin metabolism. Adv Pharmacol (1968) 0.82
Storage of ATP and 5-hydroxytryptamine in blood platelets of guinea-pigs. J Physiol (1971) 0.82
Uptake, metabolism, storage, and release of 5-hydroxytryptamine in blood platelets. Res Clin Stud Headache (1970) 0.82
Drug-induced release of biogenic amines from synaptosomes and blood platelets of guinea-pigs. Neuropharmacology (1982) 0.81
The effect of 5,6-dihydroxytryptamine on sexual behaviour of male rats. Eur J Pharmacol (1972) 0.81
5-Hydroxytryptamine kinetics and activation of blood platelets in patients with essential hypertension. Hypertension (1990) 0.81
Brain capillaries as a source of homovanillic acid in cerebrospinal fluid. Brain Res (1971) 0.81
Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin. J Hypertens (1989) 0.81
Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. Biochem Pharmacol (1971) 0.81
Storage of biogenic amines in intact blood platelets of man. Dependence on a proton gradient. Mol Pharmacol (1982) 0.81